Fig. S2.

Dimeric hRELMβ has antibacterial activity. (A) SDS/PAGE analysis of hRELMβ produced in-house and commercially available hRELMβ (Shenandoah Biotechnology) under reducing (−DTT) and nonreducing (+DTT) conditions. Under nonreducing conditions, hRELMβ produced in-house migrates as a monomer while commercially available hRELMβ migrates as a dimer. (B) Antibacterial activity of monomeric hRELMβ and commercially available, dimeric hRELMβ against P. aeruginosa. Bactericidal assays were performed at least twice and repeated in triplicate within each experiment.